STAT

To solve organ shortage, states consider ‘opt-out’ organ donation laws

"Presumed consent" organ donation policies have worked well in many European countries. But efforts to introduce them in the U.S. have so far failed.
Source: PIERRE-PHILIPPE MARCOU/AFP/Getty Images

The shortage of organs for transplantation is a thorny problem. Nearly 118,000 people in the U.S. are on waiting lists for transplants of kidneys, hearts, livers, and other organs; an estimated 8,000 of them will not live to receive a transplant.

The desperate situation has spurred various searches for solutions. Scientists are working on ways to  and are developing algorithms that factor in a patient’s proximity to a transplant center along with their health characteristics. Others have suggested ways to increase the organ supply, maybe or via relaxed standards for donated organs.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks